Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,853 | 1,377 | 99.4% |
| Education | $143.75 | 7 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,700 | 105 | $0 (2024) |
| Amgen Inc. | $1,625 | 70 | $0 (2024) |
| PFIZER INC. | $1,616 | 96 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,036 | 64 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $958.68 | 43 | $0 (2024) |
| GlaxoSmithKline, LLC. | $917.46 | 70 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $865.37 | 55 | $0 (2024) |
| Allergan, Inc. | $751.48 | 77 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $649.36 | 31 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $643.41 | 40 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,319 | 173 | PFIZER INC. ($353.38) |
| 2023 | $3,241 | 163 | ABBVIE INC. ($260.14) |
| 2022 | $3,034 | 160 | Bayer HealthCare Pharmaceuticals Inc. ($246.40) |
| 2021 | $3,832 | 208 | AbbVie Inc. ($652.90) |
| 2020 | $2,057 | 131 | Allergan, Inc. ($451.68) |
| 2019 | $2,865 | 188 | Amgen Inc. ($409.64) |
| 2018 | $2,946 | 197 | Amgen Inc. ($383.69) |
| 2017 | $2,702 | 164 | Amgen Inc. ($235.47) |
All Payment Transactions
1,384 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: PAIN | ||||||
| 12/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.05 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: UROLOGY | ||||||
| 12/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/12/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: DIABETES | ||||||
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Neurology | ||||||
| 11/08/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $28.76 | General |
| 11/04/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: VACCINES | ||||||
| 11/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), PENBRAYA | Food and Beverage | In-kind items and services | $37.55 | General |
| Category: VACCINES | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 3,988 | 5,065 | $1.5M | $378,486 |
| 2022 | 26 | 3,018 | 3,622 | $1.0M | $275,967 |
| 2021 | 23 | 2,448 | 2,953 | $795,725 | $206,959 |
| 2020 | 21 | 1,915 | 2,294 | $556,488 | $139,356 |
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,078 | 1,786 | $580,450 | $132,399 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 533 | 662 | $304,520 | $73,906 | 24.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 432 | 432 | $244,080 | $67,504 | 27.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 102 | 102 | $86,904 | $28,719 | 33.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 195 | 196 | $42,140 | $14,842 | 35.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 181 | 197 | $29,550 | $9,905 | 33.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 206 | 207 | $12,420 | $7,675 | 61.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 37 | 37 | $21,645 | $7,309 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 85 | 85 | $33,745 | $6,852 | 20.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 31 | 31 | $11,625 | $6,138 | 52.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 114 | 114 | $6,840 | $4,227 | 61.8% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 90 | 94 | $16,450 | $3,791 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $11,430 | $3,075 | 26.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 516 | 582 | $6,984 | $1,985 | 28.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 134 | 138 | $8,280 | $1,675 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $7,020 | $1,579 | 22.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 26 | 27 | $6,831 | $1,569 | 23.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $2,200 | $1,439 | 65.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 89 | $5,712 | $1,154 | 20.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 50 | 54 | $1,350 | $874.80 | 64.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 16 | $2,880 | $824.00 | 28.6% |
| 90715 | Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) | Office | 2023 | 13 | 13 | $2,080 | $389.54 | 18.7% |
| 90471 | Administration of vaccine | Office | 2023 | 13 | 13 | $780.00 | $270.14 | 34.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 12 | $720.00 | $194.64 | 27.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 20 | 21 | $504.00 | $143.00 | 28.4% |
About Dr. Mark Reginato, M.D
Dr. Mark Reginato, M.D is a Internal Medicine healthcare provider based in Danville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194884502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Reginato, M.D has received a total of $23,997 in payments from pharmaceutical and medical device companies, with $3,319 received in 2024. These payments were reported across 1,384 transactions from 105 companies. The most common payment nature is "Food and Beverage" ($23,853).
As a Medicare-enrolled provider, Reginato has provided services to 11,369 Medicare beneficiaries, totaling 13,934 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Danville, CA
- Active Since 12/08/2006
- Last Updated 02/27/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1194884502
Products in Payments
- VRAYLAR (Drug) $1,040
- JARDIANCE (Drug) $905.28
- REXULTI (Drug) $859.60
- Repatha (Biological) $640.42
- NURTEC ODT (Drug) $620.52
- XARELTO (Drug) $612.63
- NEXLETOL (Drug) $601.91
- UBRELVY (Drug) $590.92
- XIFAXAN (Drug) $542.69
- PREVNAR 20 (Biological) $527.65
- TRELEGY ELLIPTA (Drug) $472.93
- PRALUENT ALIROCUMAB INJECTION (Biological) $468.83
- Kerendia (Drug) $409.97
- APLENZIN (Drug) $408.96
- JANUVIA (Drug) $370.18
- LOREEV XR (Drug) $340.89
- Aimovig (Biological) $339.44
- Otezla (Drug) $328.56
- LEQVIO (Drug) $324.89
- Edarbi (Drug) $317.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Danville
Dr. Christopher Still, D.o, D.O
Internal Medicine — Payments: $461,951
Dr. Brendan Carry, M.d, M.D
Internal Medicine — Payments: $209,824
Prince Anand, M.d, M.D
Internal Medicine — Payments: $188,555
Jessica Mckee, D.o, D.O
Internal Medicine — Payments: $57,390
Michael Caplan, Md, MD
Internal Medicine — Payments: $41,374
Mobasser Mahmood, M.d, M.D
Internal Medicine — Payments: $23,322